Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, has initiated a voluntary recall affecting the A3/A5 Anesthesia Delivery ...

The US Food and Drug Administration (FDA) is notifying healthcare professionals of a nationwide class I recall of A3 and A5 Anesthesia Delivery System units, some of which may have a gasket leak that ...

Mindray Medical ($MR), China's largest medical device company, has launched a voluntary recall of its A3/A5 Anesthesia Delivery System, warning that the devices can ...

The FDA issued a Class 1 recall of the Mindray A3 and A5 Anesthesia Delivery System, according to the American Society of Anesthesiologists. Some of the devices may have a gasket leak which would ...

SHENZHEN, China, Aug. 30, 2023 /PRNewswire/ -- Mindray (SZSE: 300760), a global leader in providing advanced medical device solutions, has unveiled upgrades to its A7 and A5 anaesthesia systems under ...

Mindray Medical International Limited has announced FDA approval of its A5 Anesthesia System, an anesthesia delivery platform, according to a company news release. The A5’s user interface is designed ...

has initiated a voluntary recall affecting the A3/A5 Anesthesia Delivery System. Mindray has initiated this recall due to the possibility of a system leak resulting from improper seating of the CO2 ...

"The demand for more diversified and higher- quality anaesthesia practices are ever-growing. In response to this need, Mindray has developed the A7 and A5 anaesthesia systems, providing an integrated ...